Locally Advanced Pancreatic Adenocarcinoma study: Acoustic Cluster Therapy vs Modified FOLFIRINOX
Official title Acoustic Cluster Therapy (ACT) With Chemotherapy for the Treatment of Locally Advanced Pancreatic Cancer
ClinicalTrials.gov ID: NCT06850623
What this study is testing
What is Acoustic Cluster Therapy (ACT)?
An investigational combination product of the drug PS101 and ultrasound being studied for locally advanced pancreatic adenocarcinoma.
Plain-language explanation of the investigational treatment. It is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- This study is testing whether a sound wave treatment works well with chemo. It also checks how safe the mix is for people.
- Who it's for
- You may be able to join if you have locally advanced pancreatic cancer.
- What's involved
- You would get chemotherapy and a sound wave treatment called ACT. ACT uses sound waves to target the tumor.
- Time commitment
- The source text does not say how long the study lasts or how many visits are needed.
- Phase 2: a mid-size study of how well it works
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Not deemed suitable for primary curative surgery and have radiographic and pathological disease consistent with inoperable LAPC or borderline...
- Suitable to receive treatment with mFOLFIRINOX according to the Investigator's assessment.
You likely can't join if
- Any prior anti-cancer treatment for pancreatic cancer (e.g. chemotherapy, surgery, radiation).
The study team makes the final eligibility decision.
Where it is enrolling
- Scottsdale, Arizona, United States
- Stanford, California, United States
- Boston, Massachusetts, United States
- Detroit, Michigan, United States
- Philadelphia, Pennsylvania, United States
- Pittsburgh, Pennsylvania, United States
- Providence, Rhode Island, United States
- Cambridge, Cambridge, United Kingdom
- Hammersmith, London, United Kingdom
- Sutton, Surrey, United Kingdom
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Scottsdale, Arizona, United States; Stanford, California, United States; Boston, Massachusetts, United States; Detroit, Michigan, United States; Philadelphia, Pennsylvania, United States; Pittsburgh, Pennsylvania, United States and 4 more locations. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.